Category: Approval

HOUSTON–(BUSINESS WIRE)–Bio-Path Holdings, Inc. (Nasdaq: BPTH) (Bio-Path), a biotechnology
company leveraging its proprietary DNAbilize® antisense RNAi
nanoparticle technology to develop a portfolio of targeted nucleic acid
cance…

Both technologies address unmet needs for patients with celiac disease

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ImmunogenX is pleased to announce the initiation of a Phase 2 clinical
trial (named Celiac Shield™), sponsored by the Na…

New Front-Line Data Presented at Multidisciplinary Thoracic
Cancers Symposium

BOULDER, Colo. & SAN DIEGO–(BUSINESS WIRE)–Biodesix®
today presented new data demonstrating that the VeriStrat®
test is predictive of out…

DUBLIN–(BUSINESS WIRE)–The “Erectile
Dysfunction Drugs Market: Global Industry Analysis, Trends, Market Size,
and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s
offering.

The report predic…

This session will feature video segments about a family dealing with
the heartbreak of opioid addiction

CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DIP2019?src=hash" target="_blank"gt…

DUBLIN–(BUSINESS WIRE)–The “Diabetes
Care Intelligence Center 2012-2023” report has been added to ResearchAndMarkets.com’s
offering.

The Diabetes Care Intelligence Center (IC) is a global
intelligence database on …

NEWTON, Mass.–(BUSINESS WIRE)–Cheetah Medical, a Massachusetts-based leader in non-invasive fluid
management, today announced it has concluded enrollment for the Fluid
Responsiveness Evaluation in Sepsis-associated Hypotension (FRESH) t…

DUBLIN–(BUSINESS WIRE)–The “Microcarrier
Market: Global Industry Analysis, Trends, Market Size, and Forecasts up
to 2024” report has been added to ResearchAndMarkets.com’s
offering.

The report predicts the global …

DUBLIN–(BUSINESS WIRE)–The “Strategic
Development of Neural Stem and Progenitor Cell Products” report
has been added to ResearchAndMarkets.com’s offering.

While the number of adult stem cell therapies entering clinical t…

Iktos’ generative modelling AI technology enables rapid and
cost-effective design of novel drugs

Collaboration agreement enables Merck KGaA, Darmstadt, Germany
access to Iktos AI technology across…